There are better financial ratios to scare the bejesus out of Unilife investors than price to book ratios. I think its been explained before that PB ratios is a little bit outdated especially with tech companies whose IP is not captured on the balance sheet. For instance, its estimated that a single Wearable Injector contract could have an NPV of a few hundred million dollars. For a single contract. You wont see this potential captured on Unilife's balance sheet.
Microsoft has a PB of 4. Google thereabouts. Etc.
- Forums
- ASX - By Stock
- UNS
- UNS
UNS, page-12
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)